Respiratory pathogens in infants and young children with acute respiratory illness: a prospective cohort study, China, 2023–2024
Yuqing Li(Fujian Medical University), Jingxin Li(Beijing Tongren Hospital), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Mingwei Wei(Jiangsu Provincial Center for Disease Control and Prevention), Lisha Ma(Southeast University), Xiujuan Zhao(Xian Center for Disease Control and Prevention), Yuanbao Liu(Jiangsu Provincial Center for Disease Control and Prevention), Xiang Huo(Jiangsu Provincial Center for Disease Control and Prevention), Ran Tao(National Institute of Standards and Technology), Li Chen(China Medical University), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Jingjing Wu(Army Medical University), Baolong Wang(Xian Center for Disease Control and Prevention), Wenqing Liu(Nanjing Medical University), Xiuyun Shi(Xian Center for Disease Control and Prevention), Runjie Qi(Nanjing Medical University), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Tao Wu(Jiangsu Provincial Center for Disease Control and Prevention), Suyang Qi(Xian Center for Disease Control and Prevention)
Cited by 2
Related Papers
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204